Enterprise AI starts here. Our customers are leaders in their field and their commitment to solving complex, high value problems for their stakeholders make them perfect partners for our technology.
Intermountain Healthcare is using Ayasdi to develop, deploy and measure clinical pathways, the critical element in understanding and measuring clinical variation.
Ayasdi is partnered with this leading global security and aerospace company to uncover insights from complex, multi-attribute program performance data – previously hidden or overlooked by conventional analytics.
Ayasdi is working with this leading financial services provider on its Digital Private Banking initiatives seeking to arm the institution by uncovering subtle signals across their massive and complex data sets.
Ayasdi is collaborating with this global technology powerhouse helping them to accelerate insight discovery from their most challenging and complex problems.
The Ayasdi software will be at the center of Citi’s Data Center of Excellence. By automating the data-to-value process, Citi will be able to reduce the time to insights, saving them and their customers millions of dollars.
Mercy is committed to using advanced technology to transform healthcare. Working with Ayasdi, we are taking a powerful new approach to care pathways, using data as never before to deliver the transformative health experience that Mercy strives to provide every day.
As one of the largest medical genetics centers in the United States, we conduct pioneering research to identify the genetic susceptibilities--or predispositions-- of many diseases, including cancer. Ayasdi has already helped us glean new insights that will lead to breakthrough drug discoveries.
Upstream oil and gas activities on major hydrocarbon assets -- such as exploration, appraisal, and field development -- often require significant capital resources and billions of dollars. We are excited about working with Ayasdi to glean new insights from subsurface geological, geophysical, petrophysical, and engineering production data. More importantly, we can then optimize development planning for unconventional shale and deepwater assets in North America and around the world.
Johnson & Johnson
Janssen, a pharmaceutical company of Johnson & Johnson, is is using Ayasdi to expedite drug discovery and transform go to market planning.
Department of Homeland Security
Ayasdi is helping the DHS identify threats to our national transportation system.
UCSF Medical Center
Traumatic brain injury (TBI) remains a major cause of death and disability. Identification and classification of patients most likely to benefit from treatment is considered one of the most significant challenges. Using Ayasdi’s solution with Topological Data Analysis, we identified distinct groups within the patients thus enabling us to tailor effective treatment that increases survival rate. This is a major breakthrough in TBI diagnosis and treatment!
Ayasdi is collaborating with Merck, one of the world's largest pharmaceutical companies, to discover insights and analyze datasets for drug discovery and genomic research.
Ayasdi has partnered with this top 20 pharmaceutical company to accelerate drug discovery and develop precision medicine strategies.
Ayasdi is working with this global healthcare company and leader in diabetes care to expedite drug discovery and craft precise treatment paths.
This strategic integrator is using Ayasdi to work on complex communications problems.
Department of Defense
Ayasdi supports the Department of Defense by helping identify threats to national defense.
Ayasdi has worked with DARPA on a series of projects that seek to build understanding from complex, disparate datasets.
Ayasdi's use of Topological Data Analysis (TDA) is ground-breaking, and Ayasdi's technology makes it easy for anyone to mine and discover insights in large, multi-dimensional data sets to drive rapid innovation in clinical trials and drug discovery.
Using Ayasdi's solution, which employs Topological Data Analysis (TDA) methods, the USDA reconstructed the relationship structure of E. coli O157:H7 survival in 32 soils (16 organic, 16 conventional) from California (CA) and Arizona (AZ) with a multiresolution output. The analysis revealed a complex interaction between E. coli O157:H7, soil microbiota, and soil properties in the survival of this pathogen in the soils studied.
The Intelligence Advanced Research Projects Activity is a US research and intelligence agency under the Director of National Intelligence.